ArticleDiagnostic pathology2008

Development of automated brightfield double in situ hybridization (BDISH) application for HER2 gene and chromosome 17 centromere (CEN 17) for breast carcinomas and an assay performance comparison to manual dual color HER2 fluorescence in situ hybridization (FISH).

Hiroaki Nitta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.